Efficacy, Safety and Tolerability of NP-120 on Idiopathic Pulmonary Fibrosis and Its Associated Cough
Clinical trial NCT04318704 · COMPLETED
Trial details
- NCT number
- NCT04318704
- Sponsor
- Algernon Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-29
- Primary completion
- 2022-05-10
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.